However, the group said its executive chairman, Lim Han Weng, is currently engaged in “exploratory discussions” with various parties concerning potential corporate proposals related to their ...

In exploratory, descriptive analyses, the combination of relatlimab and nivolumab extended PFS regardless of pre-specified subgroups and stratification factors, BMS said. Safety-wise no new ...

Always know what to expect from your data.